SCHEMBL1250892

SCHEMBL1250892

O=C(O)C1CCC(O)CN1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.47
ACE P12821 8/20 0.34
REN P00797 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1250894 1.00 ATM (0.47) ATMACEREN
SCHEMBL1250891 1.00 ATM (0.47) ATMACEREN
SCHEMBL28531386 1.00 ATM (0.47) ATMACEREN
SCHEMBL28485257 0.83 ATM (0.69) ATMACEREN
SCHEMBL18187482 0.83 ATM (0.69) ATMACEREN
SCHEMBL21441513 0.83 ATM (0.69) ATMACEREN
SCHEMBL18187464 0.83 ATM (0.69) ATMACEREN
SCHEMBL18187463 0.83 ATM (0.69) ATMACEREN
SCHEMBL4278865 0.80 ATM (0.70) ATMACE
SCHEMBL1249542 0.80 ATM (0.70) ATMACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111542521-B RAD51 inhibitors 赛泰尔治疗公司 2024-02-23 CN disclosed
CN-114057740-A Spirocyclic pyrimidone derivatives, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2022-02-18 CN disclosed
CN-104892490-B For the compound for the midbody compound for preparing optical activity diazocine alkane derivatives 明治制果药业株式会社 2017-07-21 CN disclosed
CN-103328476-B Optically active diazacyclooctane derivative and preparation method thereof 明治制果药业株式会社 2016-12-28 CN disclosed
WO-2016089722-A1 HYDROXYMETHYL PIPERIDINE OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2016-06-09 WO disclosed
EP-2279737-B1 Heterocyclic compounds that are active as beta lactamase inhibitors NOVEXEL (FR) 2012-10-31 EP disclosed
EP-2279737-A1 Heterocyclic compounds that are active as beta lactamase inhibitors NOVEXEL (FR) 2011-02-02 EP disclosed
EP-1480644-B1 NOVEL HETEROCYCLIC COMPOUNDS WHICH ARE ACTIVE AS INHIBITORS OF BETA+LACTAMASES NOVEXEL (FR) 2010-10-13 EP disclosed
EP-1480644-A2 NOVEL HETEROCYCLIC COMPOUNDS WHICH ARE ACTIVE AS INHIBITORS OF BETA+LACTAMASES Aventis Pharma S.A. (FR) 2004-12-01 EP disclosed
EP-1307457-B1 AZABICYCLIC COMPOUNDS, PREPARATION THEREOF AND USE AS MEDICINES, IN PARTICULAR AS ANTIBACTERIAL AGENTS AVENTIS PHARMA SA (FR) 2004-04-07 EP disclosed
WO-2003063864-A2 HETEROCYCLIC COMPOUNDS WHICH ARE ACTIVE AS INHIBITORS OF BETA LACTAMASES AVENTIS PHARMA S.A. (FR) 2003-08-07 WO disclosed